Colin Stott
Chief Operating Officer bei ALTEROLA BIOTECH, INC.
Vermögen: 708 909 $ am 31.03.2024
Profil
Colin G.
Stott is the founder of Phytotherapeutix Holdings Ltd.
(founded in 2020) and Phytotherapeutix Ltd.
(founded in 2019).
He is currently an Independent Director at Cardiol Therapeutics, Inc. (since 2019) and the Chief Operating Officer & Director at Alterola Biotech, Inc. (since 2021).
He previously worked as the Chief Operating Officer & Director at Alterola Biotech, Inc. (California), Director-Scientific Affairs at GW Pharmaceuticals Ltd.
(from 2001 to 2019), Manager-Clinical Projects at Phytopharm Plc (in 1999), and Manager-Clinical Programme at Napp Pharmaceuticals Ltd.
(in 1990).
He was also the Chief Operating Officer at Alinova Biosciences Ltd.
(from 2019 to 2020).
Mr. Stott received his undergraduate degree from Loughborough University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALTEROLA BIOTECH INC.
8,15% | 28.06.2023 | 112 746 006 ( 8,15% ) | 450 984 $ | 31.03.2024 |
| 05.04.2024 | 142 500 ( 0,22% ) | 257 925 $ | 31.03.2024 |
Aktive Positionen von Colin Stott
| Unternehmen | Position | Beginn |
|---|---|---|
| ALTEROLA BIOTECH, INC. | Chief Operating Officer | 21.06.2021 |
| CARDIOL THERAPEUTICS INC. | Director/Board Member | 03.12.2019 |
| Phytotherapeutix Holdings Ltd. | Chief Executive Officer | 01.11.2020 |
| Phytotherapeutix Ltd. | Chief Executive Officer | 01.04.2019 |
Ehemalige bekannte Positionen von Colin Stott
| Unternehmen | Position | Ende |
|---|---|---|
| Alinova Biosciences Ltd. | Chief Operating Officer | 01.12.2020 |
| GW PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.05.2019 |
Phytopharm Plc
 Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Corporate Officer/Principal | 01.01.1999 |
Napp Pharmaceuticals Ltd.
 Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceuticals Ltd. manufactures and wholesales pharmaceutical products. It offers analgesic, oncology and respiratory products and provides oral, transdermal, and parenteral delivery of products. The company was founded in 1923 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 02.01.1990 |
| ALTEROLA BIOTECH, INC. | Chief Operating Officer | - |
Ausbildung von Colin Stott
| Loughborough University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Alterola Biotech, Inc. (California)
 Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Alterola Biotech, Inc. is a development stage company. It engages in the development of chewing gums for the delivery of nutraceutical and functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant. The company was founded on July 21, 2008 and is headquartered in Walnut, CA. | Process Industries |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Napp Pharmaceuticals Ltd.
Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceuticals Ltd. manufactures and wholesales pharmaceutical products. It offers analgesic, oncology and respiratory products and provides oral, transdermal, and parenteral delivery of products. The company was founded in 1923 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Alinova Biosciences Ltd. | |
| Alterola Biotech, Inc. | |
| Phytotherapeutix Holdings Ltd. | |
| Phytotherapeutix Ltd. |
